Skip to content
Updates

A log of what shipped and what is next.

We publish plainly. No press copy, no launch videos, no "we are thrilled" posts. Just dated entries when something real happened.

  1. October 2026Team

    Three advisers named.

    Dr Kei Woldendorp (cardiothoracic surgeon, Royal Prince Alfred Hospital; pro bono clinical adviser), Chris Boyd-Skinner (digital health governance and standards) and Julie Frappier (health economist, Data 4 Actions) now advise Aescia.

    Meet the team

  2. October 2026Programmes

    Aescia joins the Cicada Innovations Stride accelerator.

    Aescia started Stride, Cicada Innovations’ fully funded health-technology accelerator in Sydney, in October 2026.

  3. September 2026Clients

    St. Boniface Hospital becomes our first paying client.

    After seeking quotes from several virtual care vendors, the TPD-CONNECT team at St. Boniface Hospital in Winnipeg chose Aescia and committed payment from its seed grant for co-design and a first prototype. Dr Shuangbo Liu has also costed Aescia into two national grant applications now under review.

  4. September 2026Trial

    SAFE-Discharge passes 100 participants.

    The SAFE-Discharge evaluation at the Royal Prince Alfred Hospital cardiothoracic surgical unit has enrolled 103 patients since it went live in June 2026. Patients who start checking in straight after discharge typically do so on 83% of days. Clinical results will come from the hospital when the study reports.

  5. 17 August 2026Grants

    St. Boniface seed grant awarded for the TPD-CONNECT study.

    Dr Shuangbo Liu at St. Boniface Hospital in Winnipeg has won a St. Boniface cardiovascular seed grant, funded through the National Bank Cardiac Classic, for TPD-CONNECT. It is a 12-month study that co-designs and prototypes tailored post-discharge support for cardiac patients. Aescia is a named collaborator, configuring the platform and building the prototype. Dr Liu is the principal applicant and the work runs at St. Boniface.

  6. 17 July 2026Tools

    A free colonoscopy surveillance interval reference.

    Published an open surveillance-interval reference for clinicians. Enter what a colonoscopy found and it returns the recommended interval together with the wording of the guideline it came from, across six guideline sets covering the United States, Ontario, Alberta, British Columbia, Australia, and Europe. It runs in the browser, needs no account, and stores nothing.

    Open the reference

  7. June 2026Trial

    SAFE-Discharge goes live at Royal Prince Alfred Hospital.

    SAFE-Discharge, a prospective single-centre evaluation of Aescia for Hospitals in adults recovering from cardiothoracic surgery, went live at the Royal Prince Alfred Hospital cardiothoracic surgical unit in June 2026. It is registered with the Australian New Zealand Clinical Trials Registry and sponsored by Sydney Local Health District.

    Trial registration

  8. 24 April 2026Programme

    Aescia enrols in MTAA MedTech Compass.

    Aescia has joined the Medical Technology Association of Australia's MedTech Compass program, which supports Australian medtech companies moving from concept to commercial adoption across regulatory, reimbursement, and clinical evidence.

    MTAA MedTech Compass

  9. 24 April 2026Site

    Team, partners, and a progress log on the site.

    Published the operating team, added trial-site and research-institute affiliations, unified the contact flow, and started this updates log. Clinic pricing stays explicit: no per-seat math.

  10. 24 April 2026Ethics

    SAFE-Discharge ethics approval.

    The SAFE-Discharge trial at Royal Prince Alfred Hospital has cleared human research ethics review. Site-specific governance and IT assessments follow. No trial recruitment on this site; enrolment happens through the RPAH cardiothoracic unit under ethics approval.

  11. 15 April 2026Paediatrics

    CHEO Research Institute PMF programme kickoff.

    Aescia joined the Product-Market-Fit programme at the CHEO Research Institute in Ottawa, with a paediatric-respiratory post-discharge pathway as the working focus. Four candidate specialties under evaluation inside the programme: paediatric respiratory, paediatric cardiothoracic adjacency, paediatric gastroenterology, and paediatric oncology.

  12. 14 April 2026Evidence

    Bowel-preparation evidence base compiled.

    Compiled a ten-document evidence base covering international guidelines, digital interventions, operational economics, diabetes and anticoagulant management, GLP-1, and special populations for colonoscopy preparation. Underpins the clinician-authored prep pathway going into design-partner pilots.

  13. 13 April 2026Product

    Aescia for Clinics MVP feature-complete.

    End-to-end walkthrough across patient, clinician, and admin flows. Pathway authoring, multichannel reminders, GLP-1 overlay, diabetic and anticoagulant scenarios, recall tracking, and structured export. Production deploy follows once production database and EMR integration targets land.

  14. 20 October 2025Press

    Concordia News features Aescia in Beat the Odds program.

    Aescia participated in Concordia University's Beat the Odds hiring event through the District 3 Innovation Hub. The program connects Montreal students with early-stage startups; Aescia hired its first Beat the Odds intern through the initiative.

    Concordia News

  15. September 2025Programme

    Aescia joins District 3 at Concordia University.

    Aescia joined District 3, Concordia's innovation hub for bio, health, and high-tech startups. The programme provides coaching, mentorship, and access to Montréal's startup ecosystem.

    District 3

Want to follow along? Write to us and we will put you on a short update list.

Request a briefing